LFWD
Lifeward Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$6.98
−1.69%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 21.8M | 22.0M | 25.7M | 13.9M | 5.5M |
| Cost of Revenue | 14.0M | 13.6M | 17.4M | 9.4M | 3.6M |
| Gross Profit | 7.8M | 8.4M | 8.2M | 4.5M | 1.9M |
| Operating Expenses | |||||
| R&D Expense | 9.2M | 3.2M | 4.6M | 4.1M | 4.0M |
| SG&A Expense | 21.4M | 22.1M | 23.1M | 23.9M | 17.0M |
| General & Admin Expense | 8.4M | 8.2M | 5.2M | 10.0M | 7.1M |
| Selling & Marketing Expense | 13.1M | 13.9M | 17.9M | 13.9M | 9.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 30.6M | 25.3M | 27.8M | 28.1M | 21.0M |
| Cost and Expenses | 44.6M | 38.9M | 45.2M | 37.5M | 24.6M |
| Operating Income (EBIT) | (22.7M) | (16.9M) | (19.6M) | (23.6M) | (19.1M) |
| Non-Operating | |||||
| Interest Income | 56.0K | — | 643.0K | 1.4M | — |
| Interest Expense | 1.3M | 295.0K | 128.0K | 20.0K | 22.0K |
| Net Interest Income | (1.2M) | (295.0K) | 515.0K | 1.3M | (22.0K) |
| Other Non-Op Income/Expense | (8.1M) | (3.1M) | (9.3M) | 1.5M | — |
| Non-Operating Income (excl Interest) | 6.8M | 2.8M | 9.2M | (1.5M) | (22.0K) |
| EBT (Pre-Tax Income) | (30.9M) | (20.0M) | (28.9M) | (22.1M) | (19.1M) |
| Income Tax Expense | (50.0K) | (55.0K) | 43.0K | (12.0K) | 467.0K |
| Bottom Line | |||||
| Net Income | (30.8M) | (19.9M) | (28.9M) | (22.1M) | (19.6M) |
| Earnings from Cont. Ops | (30.8M) | (19.9M) | (28.9M) | (22.1M) | (19.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (30.8M) | (19.9M) | (28.9M) | (22.1M) | (19.6M) |
| Per Share | |||||
| Basic EPS | ($16.82) | ($17.16) | ($39.96) | ($31.08) | ($26.40) |
| Diluted EPS | ($16.82) | ($17.16) | ($39.96) | ($31.08) | ($26.40) |
| Revenue Per Share | $7.80 | $1.90 | $35.45 | $19.49 | $7.42 |
| Shares | |||||
| Basic Shares Outstanding | 2.8M | 11.6M | 723983 | 710657 | 742308 |
| Diluted Shares Outstanding | 2.8M | 11.6M | 723983 | 710657 | 742308 |
| Profitability Metrics | |||||
| EBITDA | (24.4M) | (19.3M) | (24.9M) | (20.3M) | (18.9M) |
| D&A | 5.2M | 333.0K | 3.8M | 1.8M | 202.0K |
| EBIT | (29.6M) | (19.7M) | (28.8M) | (22.1M) | (19.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026